1064 related articles for article (PubMed ID: 16303268)
41. Evasion of opsonization of macromolecules using novel surface-modification and biological-camouflage-mediated techniques for next-generation drug delivery.
Mehta P; Shende P
Cell Biochem Funct; 2023 Dec; 41(8):1031-1043. PubMed ID: 37933222
[TBL] [Abstract][Full Text] [Related]
42. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
[TBL] [Abstract][Full Text] [Related]
43. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
44. Degradable poly(beta-amino ester) nanoparticles for cancer cytoplasmic drug delivery.
Shen Y; Tang H; Zhan Y; Van Kirk EA; Murdoch WJ
Nanomedicine; 2009 Jun; 5(2):192-201. PubMed ID: 19223244
[TBL] [Abstract][Full Text] [Related]
45. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells.
Hu Y; Xie J; Tong YW; Wang CH
J Control Release; 2007 Mar; 118(1):7-17. PubMed ID: 17241684
[TBL] [Abstract][Full Text] [Related]
46. Facile, efficient approach to accomplish tunable chemistries and variable biodistributions for shell cross-linked nanoparticles.
Sun G; Hagooly A; Xu J; Nyström AM; Li Z; Rossin R; Moore DA; Wooley KL; Welch MJ
Biomacromolecules; 2008 Jul; 9(7):1997-2006. PubMed ID: 18510359
[TBL] [Abstract][Full Text] [Related]
47. Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation.
Chambers E; Mitragotri S
Exp Biol Med (Maywood); 2007 Jul; 232(7):958-66. PubMed ID: 17609513
[TBL] [Abstract][Full Text] [Related]
48. Characterization of PLL-g-PEG-DNA nanoparticles for the delivery of therapeutic DNA.
Rimann M; Lühmann T; Textor M; Guerino B; Ogier J; Hall H
Bioconjug Chem; 2008 Feb; 19(2):548-57. PubMed ID: 18173226
[TBL] [Abstract][Full Text] [Related]
49. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier.
Liu L; Guo K; Lu J; Venkatraman SS; Luo D; Ng KC; Ling EA; Moochhala S; Yang YY
Biomaterials; 2008 Apr; 29(10):1509-17. PubMed ID: 18155137
[TBL] [Abstract][Full Text] [Related]
50. Engineering Well-Characterized PEG-Coated Nanoparticles for Elucidating Biological Barriers to Drug Delivery.
Yang Q; Lai SK
Methods Mol Biol; 2017; 1530():125-137. PubMed ID: 28150200
[TBL] [Abstract][Full Text] [Related]
51. Effects of ionic strength and surface charge on protein adsorption at PEGylated surfaces.
Pasche S; Vörös J; Griesser HJ; Spencer ND; Textor M
J Phys Chem B; 2005 Sep; 109(37):17545-52. PubMed ID: 16853244
[TBL] [Abstract][Full Text] [Related]
52. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.
Lu W; Wan J; She Z; Jiang X
J Control Release; 2007 Mar; 118(1):38-53. PubMed ID: 17240471
[TBL] [Abstract][Full Text] [Related]
53. High salt stability and protein resistance of poly(L-lysine)-g-poly(ethylene glycol) copolymers covalently immobilized via aldehyde plasma polymer interlayers on inorganic and polymeric substrates.
Blättler TM; Pasche S; Textor M; Griesser HJ
Langmuir; 2006 Jun; 22(13):5760-9. PubMed ID: 16768506
[TBL] [Abstract][Full Text] [Related]
54. Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents.
Bae Y; Diezi TA; Zhao A; Kwon GS
J Control Release; 2007 Oct; 122(3):324-30. PubMed ID: 17669540
[TBL] [Abstract][Full Text] [Related]
55. Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers.
Shehata T; Ogawara K; Higaki K; Kimura T
Int J Pharm; 2008 Jul; 359(1-2):272-9. PubMed ID: 18486370
[TBL] [Abstract][Full Text] [Related]
56. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.
Suk JS; Xu Q; Kim N; Hanes J; Ensign LM
Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):28-51. PubMed ID: 26456916
[TBL] [Abstract][Full Text] [Related]
57. Identification of polyethylene glycol-resistant macrophages on stealth imaging in vitro using fluorescent organosilica nanoparticles.
Nakamura M; Hayashi K; Nakano M; Kanadani T; Miyamoto K; Kori T; Horikawa K
ACS Nano; 2015 Feb; 9(2):1058-71. PubMed ID: 25629765
[TBL] [Abstract][Full Text] [Related]
58. Phagocytosis of synthetic particles in earthworms. Effect of antigenic stimulation and opsonization.
Bilej M; Vĕtvicka V; Tucková L; Trebichavský I; Koukal M; Síma P
Folia Biol (Praha); 1990; 36(6):273-80. PubMed ID: 2279582
[TBL] [Abstract][Full Text] [Related]
59. Serum albumin 'camouflage' of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics.
Pitek AS; Jameson SA; Veliz FA; Shukla S; Steinmetz NF
Biomaterials; 2016 May; 89():89-97. PubMed ID: 26950168
[TBL] [Abstract][Full Text] [Related]
60. Nanomedicine for respiratory diseases.
Swai H; Semete B; Kalombo L; Chelule P; Kisich K; Sievers B
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):255-63. PubMed ID: 20049795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
